<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23062" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hydatidiform Mole</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ghassemzadeh</surname>
            <given-names>Sassan</given-names>
          </name>
          <aff>Riverside Comm Hosp, UC Riverside</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Farci</surname>
            <given-names>Fabiola</given-names>
          </name>
          <aff>Pisa University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kang</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>University of California Riverside School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sassan Ghassemzadeh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fabiola Farci declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Kang declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23062.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A hydatiform mole (also known as a molar pregnancy) is a gestational trophoblastic disease (GTD), which originates from the placenta and can metastasize. It is unique in that the tumor originates from gestational tissue rather than from maternal tissue. Hydatiform moles (HM) are categorized as complete and partial and are usually considered the noninvasive form of gestational trophoblastic disease. While hydatiform moles are typically deemed benign, they are premalignant and do have the potential to become malignant and invasive. This activity describes the pathophysiology, evaluation, and management of hydatiform moles and highlights the role of the interprofessional team in the management of affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of a hydatiform mole.</p></list-item><list-item><p>Describe the presentation of a patient with a hydatiform mole.</p></list-item><list-item><p>Review the treatment and management options available for hydatiform moles.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication to advance the treatment of hydatiform moles and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23062&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23062">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23062.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hydatiform mole (also known as molar pregnancy) is a subcategory of diseases under gestational trophoblastic disease (GTD), which originates from the placenta and can metastasize. It is unique because the tumor originates from gestational tissue rather than from maternal tissue. Other forms of&#x000a0;gestational trophoblastic disease&#x000a0;include gestational choriocarcinoma (which can be extremely&#x000a0;malignant and invasive) and placental site trophoblastic tumors. Hydatiform mole (HM) is categorized as a complete and partial mole and is usually considered the noninvasive form of&#x000a0;gestational trophoblastic disease. Although hydatiform moles are usually considered benign, they are premalignant and do&#x000a0;have the potential to become malignant and invasive.<xref ref-type="bibr" rid="article-23062.r1">[1]</xref><xref ref-type="bibr" rid="article-23062.r2">[2]</xref><xref ref-type="bibr" rid="article-23062.r3">[3]</xref></p>
      </sec>
      <sec id="article-23062.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>As described previously, hydatiform moles are divided into complete and partial moles. Complete mole is the most common type and does not contain fetal parts, whereas in a partial mole there might be identifiable fetal residues.&#x000a0;Complete moles are typically diploid, whereas partial moles are triploid. Complete moles tend to&#x000a0;cause higher levels of the human chorionic gonadotropin (hCG), which is one of the main clinical features of this process. In complete moles, the karyotype is 46,XX 90% of the time and 46,XY 10% of the time. It arises when an enucleated egg is fertilized either by two sperms or by a haploid sperm that then duplicates and therefore, only paternal DNA is expressed. On the other hand, in partial moles, the karyotype is 90% of the time triploid and either 69,XXX or 69,XXY. This karyotype arises when a normal sperm subsequently fertilizes haploid ovum duplicates and or when two sperms fertilize a haploid ovum. In partial moles, both maternal and paternal DNA is expressed.<xref ref-type="bibr" rid="article-23062.r4">[4]</xref><xref ref-type="bibr" rid="article-23062.r5">[5]</xref><xref ref-type="bibr" rid="article-23062.r6">[6]</xref></p>
      </sec>
      <sec id="article-23062.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>There is a very&#x000a0;low frequency of hydatiform moles. In North America and Europe, the frequency has been described as 60 to 120/100,000 pregnancies for hydatiform moles. The frequency has been shown to be higher in other countries of the world. Certain risk factors increase the prevalence of molar pregnancies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Extremes of maternal age:</p>
            <list list-type="bullet">
              <list-item>
                <p>Greater than 35&#x000a0;years old carries a&#x000a0; five to ten-fold increased risk&#x000a0;risk</p>
              </list-item>
              <list-item>
                <p>Early teenage years, usually less than 20 years old</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Previous molar pregnancy increases the risk 1% to 2% for future pregnancies</p>
          </list-item>
          <list-item>
            <p>Women with previous spontaneous abortions or infertilities</p>
          </list-item>
          <list-item>
            <p>Dietary factors including&#x000a0;patients&#x000a0;that have diets deficient in carotene (vitamin A precursor) and animal fats</p>
          </list-item>
          <list-item>
            <p>Smoking</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23062.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>As described previously, hydatiform moles arise from gestational tissue. In complete hydatidiform mole, there is no fetal tissue present; in partial hydatiform moles, there is some residual fetal tissue. Both are due to the over-proliferation of chorionic villi. It is still unclear if the trophoblastic transformation causes vascular obliteration and fetal death or, in another theory, a spontaneous stillbirth causes villous dysmorphism and trophoblastic proliferation. Several studies&#x000a0;<xref ref-type="bibr" rid="article-23062.r7">[7]</xref><xref ref-type="bibr" rid="article-23062.r8">[8]</xref><xref ref-type="bibr" rid="article-23062.r9">[9]</xref><xref ref-type="bibr" rid="article-23062.r10">[10]</xref><xref ref-type="bibr" rid="article-23062.r11">[11]</xref>&#x000a0;reveal a severe&#x000a0;vasculogenic deficit in trophoblastic diseases, with significantly retarded angiogenesis in early complete mole,&#x000a0;progressive&#x000a0;accumulation of fluids, and subsequent formation of cystic spaces ("cistern"). In complete moles an enucleated egg is fertilized either by two sperm or, more commonly, monospermic arising from a haploid sperm which&#x000a0;endoreduplicates, resulting in only paternal DNA being expressed; this aberration lacks mitochondria, as&#x000a0;mitochondrial DNA is maternally&#x000a0;derived. Conversely, in a partial hydatiform mole, a haploid ovum either duplicates and fertilized by normal sperm, or a haploid ovum is fertilized by two sperm, resulting in both the expression of both maternal and paternal DNA.<xref ref-type="bibr" rid="article-23062.r12">[12]</xref>&#x000a0;In brief, complete moles are diploid (46,XX; 46,XY)&#x000a0;while&#x000a0;most partial moles are triploid (69,XXY; XXX; XYY).&#x000a0;Triploid or tetraploid complete&#x000a0;moles are androgenetic (since they lack maternal chromosomes) while tetraploid partial moles&#x000a0;have&#x000a0;maternal contributions. Hydatiform mole is characterized by chromosomal abnormalities, which allow for&#x000a0;malignant transformation in choriocarcinoma.&#x000a0;The most common alteration leading to malignant transformation are the activation of oncogenes, inactivation of tumor&#x000a0;suppressors, and the alteration of telomerase regulation.</p>
      </sec>
      <sec id="article-23062.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Hydatiform mole is characterized by an overgrown&#x000a0;villous trophoblast with cystic "swollen" villi. Macroscopically&#x000a0;can be visible,&#x000a0;the second&#x000a0;trimester, as clusters of vesicles (similar to small grapes)&#x000a0;developed from the transformation of chorionic villi. Complete mole differs from partial mole, in cytogenetic and microscopical appearance. Important is a complete&#x000a0;lack of embryonic/fetal tissue in complete moles and&#x000a0;the presence of-of embryonic tissue in partial moles.</p>
        <p>Microscopically, a complete mole has markedly&#x000a0;hydropic and deformed chorionic villi with the formation of "cisterns" containing stromal fluid; there is a peripheral&#x000a0;proliferation of both&#x000a0;cytotrophoblast and syncytiotrophoblast, arranged in lace-like structures, papillary formation, or circumferential. In normal early placenta the cytotrophoblast and syncytiotrophoblast are polarized. There is the absence of fetal stromal blood vessels. An immature vascular network is otherwise present, positive for CD31, with dysmorphic features such as a complete lack of lumen. In partial mole there are&#x000a0;hydropic chorionic villi surrounded by hyperplastic trophoblasts&#x000a0;with&#x000a0;variable degrees of central cistern formation, with an irregular maze-like pattern; also, there are normal chorionic villi and embryonic or fetal tissue mixed with hydropic villi. There are recognizable&#x000a0;fetal&#x000a0;blood vessels&#x000a0;containing fetal red blood cells. The curettage material should be examined carefully, especially in first trimester pregnancies, and if a partial mole is suspected the whole specimen should be examined. The main differential diagnosis is with a hydropic abortion, where the main clue is the presence of villous edema only with microscopical evaluation and lacks cistern formation or trophoblastic proliferation. A pitfall in hydropic abortion is the presence of polar stratification of&#x000a0;anchoring trophoblast in a first-trimester placenta.&#x000a0;The villous size in hydropic abortion ranges from&#x000a0;small, to&#x000a0;medium and large.</p>
        <p>An important marker that aids in the diagnosis of the complete mole is the presence or absence of p57 in immunohistochemistry. This marker&#x000a0;is a paternal-imprint&#x000a0;inhibitor gene&#x000a0;so its expression&#x000a0;implies the maternal&#x000a0;contribution; in brief, the absence of p57 expression supports the diagnosis of androgenetic gestational disease with complete&#x000a0;mole <xref ref-type="bibr" rid="article-23062.r13">[13]</xref><xref ref-type="bibr" rid="article-23062.r14">[14]</xref><xref ref-type="bibr" rid="article-23062.r15">[15]</xref>. Moles also express&#x000a0;p53, p21, cyclin E, and MCM7.</p>
      </sec>
      <sec id="article-23062.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The presentation of the hydatiform mole is somewhat&#x000a0;different in a complete mole versus a partial mole. In fact, most partial moles are diagnosed as spontaneous abortions that are later discovered after a pathology report is obtained from the fetal tissue.</p>
        <p>Since the advent of&#x000a0;ultrasonography, the diagnosis of complete molar pregnancies has increased in the early stages of pregnancy, mainly during the first trimester. The most common symptom (in one study as high as 84% of patients) of a complete mole is vaginal bleeding in the first trimester, which is normally due to the molar tissue separating from the decidua, resulting in bleeding. The typical buzzword appearance of vaginal bleeding is described as a "prune juice" appearance. This is secondary to the accumulated blood products in the uterine cavity and resultant oxidation and liquefaction of that blood. Another symptom of a complete molar pregnancy is hyperemesis (severe nausea and vomiting), which is due to the high level of the hCG hormone circulating in the bloodstream. Some patients also endorse&#x000a0;passage of vaginal tissue described as grape-like clusters or vesicles.&#x000a0;Late findings of the disease (after the first trimester around 14 to 16 weeks of pregnancy) including signs and symptoms of hyperthyroidism, including tachycardia and tremors, again caused by the high levels of circulating hCG. Other late sequelae are pre-eclampsia, which is pregnancy-induced hypertension and proteinuria and/or end-organ dysfunction occurring typically after 34 weeks of pregnancy. When a patient less than 20 weeks pregnant presents with signs and symptoms of pre-eclampsia, a complete molar pregnancy should highly be suspected. In very advanced cases, patients present with severe respiratory distress possible from embolism of the trophoblastic tissue into the lungs.</p>
        <p>The presentation of a partial hydatiform mole is usually less dramatic than that of a complete mole. These patients typically present as described before with symptoms similar to a threatened or spontaneous abortion, including vaginal bleeding. Since partial hydatiform moles have fetal tissue, on examination, these patients may have fetal heart tones evident on Doppler.&#x000a0;</p>
        <p>On physical exam, in more than 50% of cases, uterine size discrepancy and date discrepancy usually takes place. In a complete mole, the uterus is usually larger than the expected gestational date of the pregnancy, whereas, in partial moles, the uterus can be smaller than the suggested date.</p>
      </sec>
      <sec id="article-23062.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>In a pregnant patient with vaginal bleeding, one should always obtain a serum quantitative hCG level and the patient's blood type. In hydatiform moles, the serum hCG levels are typically much higher than patients of the same gestational date in a normal pregnancy or ectopic pregnancy. Complete moles tend to&#x000a0;have&#x000a0;very&#x000a0;high levels of serum hCG, typically greater than 100,000, whereas partial moles may be within the normal range for gestational age or even lower than expected. Blood type is important because most patients with complete or partial hydatiform moles present with vaginal bleeding. Therefore, Rh antibody screening needs to be performed to determine whether anti-D immunoglobulin needs to be administered if the patient is Rh(D) negative. Other laboratory tests include:</p>
        <p>Complete blood count (CBC) (to evaluate for anemia and thrombocytopenia)&#x000a0;</p>
        <p>BMP (to evaluate for electrolyte imbalance and renal insufficiency)</p>
        <p>Thyroid panel (if signs and symptoms of hyperthyroidism present)&#x000a0;</p>
        <p>Liver function tests and urinalysis (if pre-eclampsia is suspected to evaluate for transaminitis and proteinuria)</p>
        <p>Coagulation profile including PT/INR to evaluate for disseminated intravascular coagulation in severe cases.</p>
        <p>The imaging of choice in a suspected hydatiform mole is a pelvic ultrasound. In a complete mole, the ultrasound findings include a heterogeneous mass in the uterine cavity with multiple anechoic spaces, most commonly referred to as a "snowstorm" appearance. These small cystic areas are typically the hydropic villi described previously in the histopathology section. Furthermore, there is the absence of an embryo or fetus, and no amniotic fluid is present. In a partial mole, there typically is the finding of a fetus which may be viable, the presence of&#x000a0;amniotic fluid, and the placenta appears to have enlarged, cystic spaces (often described as "Swiss cheese" appearance). In one study, it was noted that&#x000a0;partial moles were diagnosed as a missed or incomplete abortion in 15% to 60% of cases.&#x000a0;</p>
        <p>If a molar pregnancy is diagnosed, the next step is typically a&#x000a0;CT scan and PET scan to stage the disease. Furthermore, a chest x-ray should be obtained if the patient's initial symptoms included any signs of respiratory distress or increased breathing to evaluate for pulmonary edema.<xref ref-type="bibr" rid="article-23062.r16">[16]</xref><xref ref-type="bibr" rid="article-23062.r17">[17]</xref><xref ref-type="bibr" rid="article-23062.r18">[18]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23062.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In the emergency department,&#x000a0;the priority is clinical stabilization.&#x000a0;If there is any evidence of respiratory distress and pulmonary edema, non-invasive positive pressure ventilation (such as BiPAP) or mechanical ventilation should be started. Furthermore, if there are signs of symptoms of eclampsia (late stage of pre-eclampsia), including seizures, one should initiate appropriate&#x000a0;management, including benzodiazepines and magnesium sulfate administration. If the patient has signs of pre-eclampsia, urgent blood pressure control is necessary with medications such as hydralazine and labetalol. If there are signs and symptoms of hyperthyroidism, practitioners should initiate proper treatment, including beta-blockers, and monitor for thyroid storm. If severe anemia is present, the clinician should consider a blood transfusion. As discussed earlier, if a patient is Rh(D) negative, the physician should administer the anti-D immunoglobulin.</p>
        <p>Once the patient is stabilized, an emergent obstetrics consultation is necessary for the likely need for dilation and curettage (D and C). In patients with advanced maternal age typically greater than 40 years old and those who have completed childbearing, hysterectomy is often performed instead of a D and C. Hysterectomy, however, does not completely eliminate the risk of metastatic disease. After the evacuation of the molar pregnancy, the hCG levels should be monitored; if remain elevated, there is evidence of persistent or invasive disease requiring at times chemotherapy. A gynecological oncologist consultation is usually necessary in these cases to guide therapy.</p>
      </sec>
      <sec id="article-23062.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Androgenetic/biparental mosaic conceptions</p>
          </list-item>
          <list-item>
            <p>Abnormal villous morphology</p>
          </list-item>
          <list-item>
            <p>Early abortus with trophoblastic hyperplasia</p>
          </list-item>
          <list-item>
            <p>Hydropic abortus</p>
          </list-item>
          <list-item>
            <p>Hyperemesis gravidarum</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Hyperthyroidism</p>
          </list-item>
          <list-item>
            <p>Malignant hypertension</p>
          </list-item>
          <list-item>
            <p>Placental mesenchymal dysplasia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23062.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A molar pregnancy is best managed with an interprofessional team. Once molar pregnancy is diagnosed and an obstetric/gynecology consultation is obtained, patients are typically admitted to the hospital for surgery. Weekly serum hCG levels are obtained after surgery&#x000a0;until an undetectable level of hCG is reached (usually done in an outpatient setting). Patients with previous molar pregnancy are advised to use reliable contraception to avoid a new pregnancy. It could conflict with weekly serum hCG level testing and make it impossible to determine the occurrence of invasive molar disease. The risk of invasive disease in a complete molar pregnancy is around 15% to 20%, and in a partial molar pregnancy is 1% to 5%.</p>
      </sec>
      <sec id="article-23062.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23062&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23062">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/hydatidiform-mole/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23062">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23062/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23062">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-23062.s13">
        <fig id="article-23062.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Uterus Ultrasound,&#x000a0;Molar Pregnancy. Molar pregnancy displays a "snowstorm-like" appearance. Contributed by S Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molar__preg__US__cervix" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-23062.s14">
        <fig id="article-23062.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Hydatiform Mole. Chorionic villi with hydropic change, formation of cystic spaces and exuberant villous trophoblastic hyperplasia. Contributed by Fabiola Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hydatiform__mole3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-23062.s15">
        <fig id="article-23062.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Irregular, Indented Villi with Lace-Like Trophoblast Proliferation. Partial hydatiform mole, H/E 4x. Contributed by Fabiola Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hydatiform__mole2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-23062.s16">
        <fig id="article-23062.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Dysmorphic Villi in Hydatiform Mole. H/E 4x Contributed by Fabiola Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hydatiform__mole4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-23062.s17">
        <fig id="article-23062.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Hydropic Villi and Trophoblastic Proliferation. Hydatiform mole, H/E 4x. Contributed by Fabiola Farci, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hydatiform__mole5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-23062.s18">
        <title>References</title>
        <ref id="article-23062.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mittal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Interstitial pregnancy mimicking an invasive hydatidiform mole.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2019</year>
            <month>May</month>
            <volume>220</volume>
            <issue>5</issue>
            <fpage>501</fpage>
            <pub-id pub-id-type="pmid">31079718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarmadi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Izadi-Mood</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sanii</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Motevalli</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Inter-observer variability in the histologic criteria of diagnosis of hydatidiform moles.</article-title>
            <source>Malays J Pathol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-24</page-range>
            <pub-id pub-id-type="pmid">31025633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ning</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Morse</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Lash</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Understanding and management of gestational trophoblastic disease.</article-title>
            <source>F1000Res</source>
            <year>2019</year>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">31001418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braga</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mora</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Melo</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Nogueira-Rodrigues</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amim-Junior</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rezende-Filho</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seckl</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide.</article-title>
            <source>World J Clin Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>24</day>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>28</fpage>
            <page-range>28-37</page-range>
            <pub-id pub-id-type="pmid">30815369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yuk</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>IA</given-names>
              </name>
            </person-group>
            <article-title>Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study.</article-title>
            <source>PeerJ</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>e6490</fpage>
            <pub-id pub-id-type="pmid">30809458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The management of hydatidiform mole with lung nodule: a retrospective analysis in 53 patients.</article-title>
            <source>J Gynecol Oncol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>e16</fpage>
            <pub-id pub-id-type="pmid">30740949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Ro</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lage</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HI</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>362</fpage>
            <page-range>362-9</page-range>
            <pub-id pub-id-type="pmid">16538057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lisman</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Boer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bleker</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>van Wely</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Exalto</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vasculogenesis in complete and partial hydatidiform mole pregnancies studied with CD34 immunohistochemistry.</article-title>
            <source>Hum Reprod</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>2334</fpage>
            <page-range>2334-9</page-range>
            <pub-id pub-id-type="pmid">15878926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>YO</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Robboy</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>176</fpage>
            <page-range>176-85</page-range>
            <pub-id pub-id-type="pmid">18936691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Novac</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Niculescu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manolea</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Iliescu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Georgescu</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Com&#x00103;nescu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cernea</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Enache</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The vasculogenesis--a possible histological identification criterion for the molar pregnancy.</article-title>
            <source>Rom J Morphol Embryol</source>
            <year>2011</year>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-7</page-range>
            <pub-id pub-id-type="pmid">21424033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hussein</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Analysis of the vascular profile and CD99 protein expression in the partial and complete hydatidiform moles using quantitative CD34 immunohistochemistry.</article-title>
            <source>Exp Mol Pathol</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-50</page-range>
            <pub-id pub-id-type="pmid">20630481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Biswal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Differential expression of cyclin E, p63, and Ki-67 in gestational trophoblastic disease and its role in diagnosis and management: A prospective case-control study.</article-title>
            <source>Indian J Pathol Microbiol</source>
            <year>2019</year>
            <season>Jan-Mar</season>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-60</page-range>
            <pub-id pub-id-type="pmid">30706860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giacometti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bellan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ambrosi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dei Tos</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Cassaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>"While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review.</article-title>
            <source>Placenta</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>116</volume>
            <fpage>31</fpage>
            <page-range>31-37</page-range>
            <pub-id pub-id-type="pmid">33714612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xing</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ronnett</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.</article-title>
            <source>Mod Pathol</source>
            <year>2021</year>
            <month>May</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>961</fpage>
            <page-range>961-982</page-range>
            <pub-id pub-id-type="pmid">33024305</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takahashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okae</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kumada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yaegashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Loss of p57<sup>KIP2</sup> expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2019</year>
            <month>Dec</month>
            <day>26</day>
            <volume>116</volume>
            <issue>52</issue>
            <fpage>26606</fpage>
            <page-range>26606-26613</page-range>
            <pub-id pub-id-type="pmid">31792181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ross</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Unipan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Magee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Johns</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound diagnosis of molar pregnancy.</article-title>
            <source>Ultrasound</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-159</page-range>
            <pub-id pub-id-type="pmid">30147739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heller</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Update on the pathology of gestational trophoblastic disease.</article-title>
            <source>APMIS</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>126</volume>
            <issue>7</issue>
            <fpage>647</fpage>
            <page-range>647-654</page-range>
            <pub-id pub-id-type="pmid">30129126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23062.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ling</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Partial molar pregnancy in the cesarean scar: A case report and literature review.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>26</issue>
            <fpage>e11312</fpage>
            <pub-id pub-id-type="pmid">29953018</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
